Business Context and Reporting Period
This Form 10-Q covers United HealthCare Corporation (now UnitedHealth Group Inc.) for the quarterly period ended March 31, 1995. The company operates in the managed health care industry, primarily through owned health plans and managed health plan services. The 1994 comparative figures have been restated to include the results of Complete Health Services and Ramsay-HMO under pooling of interests accounting.
Key Financial Metrics
| Metric | Q1 1995 | Q1 1994 (Restated) |
|---|---|---|
| Total Revenues | $1,103.8 million | $903.6 million |
| Premium Revenues | $1,004.5 million | $805.0 million |
| Net Earnings | $89.4 million | $70.4 million |
| Earnings Per Share (Diluted) | $0.51 | $0.40 |
| Operating Margin | 13.0% | 12.7% |
| Cash and Cash Equivalents | $594.3 million | $225.3 million |
| Total Assets | $3,700.8 million | $3,489.5 million |
| Long-term Obligations | $25.1 million | $24.3 million |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 22.2% year-over-year, driven by a 25% increase in premium revenues. This growth was fueled by enrollment gains and the January 1995 acquisition of GenCare Health Systems, which contributed $63.9 million to the premium increase.
- Profitability: Net earnings rose 28% to $89.4 million. Operating income increased 24.7% to $143.1 million, with the operating margin improving from 12.7% to 13.0%.
- Segment Performance: Owned health plan revenues grew 25.2%, while managed health plan and specialty services revenues declined 38.1% due to the sale of Diversified Pharmaceutical Services in May 1994 and changes in the Medica management agreement.
- Cash Flow: Operating cash flow was $105.9 million. However, investing activities consumed $1,035.2 million, primarily due to the $515.4 million cash purchase of GenCare and net purchases of investments.
- Liquidity: Working capital decreased from $1.24 billion to $455.6 million as the company deployed cash for the GenCare acquisition and invested in longer-term instruments.
Outlook, Risks, and Management Commentary
- Acquisition Impact: The GenCare acquisition added 230,000 members. Management expects commercial premium rate increases for the remainder of 1995 to decline slightly, anticipating a lower medical cost trend.
- Medical Loss Ratio: The medical loss ratio for owned health plans improved to 78.9% from 79.5% in the prior year, reflecting effective cost management.
- Dividends: The Board approved an annual dividend of $0.03 per share for 1995, totaling $5.2 million, paid in April 1995.
- Risks: Management cites increasing competition in certain markets, potential changes in government regulations, and the uncertainty of future health care cost inflation as key risks. There is no assurance that recent enrollment growth trends will continue.
- Investment Portfolio: The company holds approximately $1.50 billion in cash and investments available for general corporate use. The amortized cost of investments exceeded fair value by $26.8 million (net of tax), but management does not intend to realize significant losses.
Investor Verification Checklist
- Verify the integration progress and financial performance of the newly acquired GenCare Health Systems.
- Monitor the medical loss ratio trends to ensure cost containment strategies remain effective against inflation.
- Assess the impact of the sale of Diversified Pharmaceutical Services on the long-term revenue mix of the managed care segment.
- Review the company's liquidity position given the significant reduction in working capital following the GenCare acquisition.
- Track regulatory changes in state and federal jurisdictions that could affect compliance costs or operational scope.